Literature DB >> 31714001

Alterations in plasma membrane ion channel structures stimulate NLRP3 inflammasome activation in APOL1 risk milieu.

Alok Jha1, Vinod Kumar1, Shabirul Haque1, Kamesh Ayasolla1, Shourav Saha1, Xiqian Lan1, Ashwani Malhotra1, Moin A Saleem2, Karl Skorecki3, Pravin C Singhal1.   

Abstract

We evaluated alterations in the structural configurations of channels and activation of nucleotide-binding domain, leucine-rich-containing family, pyrin domain-containing-3 (span>n class="Gene">NLRP3) inflammasome formation in apolipoprotein L1 (APOL1) risk and nonrisk milieus. APOL1G1- and APOL1G2-expressing podocytes (PD) displayed enhanced K+ efflux, induction of pyroptosis, and escalated transcription of interleukin (IL)-1β and IL-18. APOL1G1- and APOL1G2-expressing PD promoted the transcription as well as translation of proteins involved in the formation of inflammasomes. Since glyburide (a specific inhibitor of K+ efflux channels) inhibited the transcription of NLRP3, IL-1β, and IL-18, the role of K+ efflux in the activation of inflammasomes in APOL1 risk milieu was implicated. To evaluate the role of structural alterations in K+ channels in plasma membranes, bioinformatics studies, including molecular dynamic simulation, were carried out. Superimposition of bioinformatics reconstructions of APOL1G0, G1, and G2 showed several aligned regions. The analysis of pore-lining residues revealed that Ser342 and Tyr389 are involved in APOL1G0 pore formation and the altered conformations resulting from the Ser342Gly and Ile384Met mutation in the case of APOLG1 and deletion of the Tyr389 residue in the case of APOL1G2 are expected to alter pore characteristics, including K+ ion selectivity. Analysis of multiple membrane (lipid bilayer) models of interaction with the peripheral protein, integral membrane protein, and multimer protein revealed that for an APOL1 multimer model, APOL1G0 is not energetically favorable while the APOL1G1 and APOL1G2 moieties favor the insertion of multiple ion channels into the lipid bilayer. We conclude that altered pore configurations carry the potential to facilitate K+ ion transport in APOL1 risk milieu.
© 2019 Federation of European Biochemical Societies.

Entities:  

Keywords:  K+-efflux; apolipoprotein L1; inflammasomes; lipid bilayer; pore structure

Year:  2019        PMID: 31714001      PMCID: PMC7298666          DOI: 10.1111/febs.15133

Source DB:  PubMed          Journal:  FEBS J        ISSN: 1742-464X            Impact factor:   5.542


  47 in total

1.  Bluues server: electrostatic properties of wild-type and mutated protein structures.

Authors:  Ian Walsh; Giovanni Minervini; Alessandra Corazza; Gennaro Esposito; Silvio C E Tosatto; Federico Fogolari
Journal:  Bioinformatics       Date:  2012-06-17       Impact factor: 6.937

2.  M-ZDOCK: a grid-based approach for Cn symmetric multimer docking.

Authors:  Brian Pierce; Weiwei Tong; Zhiping Weng
Journal:  Bioinformatics       Date:  2004-12-21       Impact factor: 6.937

3.  CHARMM-GUI: a web-based graphical user interface for CHARMM.

Authors:  Sunhwan Jo; Taehoon Kim; Vidyashankara G Iyer; Wonpil Im
Journal:  J Comput Chem       Date:  2008-08       Impact factor: 3.376

4.  Transgenic expression of human APOL1 risk variants in podocytes induces kidney disease in mice.

Authors:  Pazit Beckerman; Jing Bi-Karchin; Ae Seo Deok Park; Chengxiang Qiu; Patrick D Dummer; Irfana Soomro; Carine M Boustany-Kari; Steven S Pullen; Jeffrey H Miner; Chien-An A Hu; Tibor Rohacs; Kazunori Inoue; Shuta Ishibe; Moin A Saleem; Matthew B Palmer; Ana Maria Cuervo; Jeffrey B Kopp; Katalin Susztak
Journal:  Nat Med       Date:  2017-02-20       Impact factor: 53.440

5.  Apolipoprotein L, a new human high density lipoprotein apolipoprotein expressed by the pancreas. Identification, cloning, characterization, and plasma distribution of apolipoprotein L.

Authors:  P N Duchateau; C R Pullinger; R E Orellana; S T Kunitake; J Naya-Vigne; P M O'Connor; M J Malloy; J P Kane
Journal:  J Biol Chem       Date:  1997-10-10       Impact factor: 5.157

6.  The I-TASSER Suite: protein structure and function prediction.

Authors:  Jianyi Yang; Renxiang Yan; Ambrish Roy; Dong Xu; Jonathan Poisson; Yang Zhang
Journal:  Nat Methods       Date:  2015-01       Impact factor: 28.547

Review 7.  The function of apolipoproteins L.

Authors:  B Vanhollebeke; E Pays
Journal:  Cell Mol Life Sci       Date:  2006-09       Impact factor: 9.261

8.  AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibility.

Authors:  Garrett M Morris; Ruth Huey; William Lindstrom; Michel F Sanner; Richard K Belew; David S Goodsell; Arthur J Olson
Journal:  J Comput Chem       Date:  2009-12       Impact factor: 3.376

Review 9.  Apolipoprotein L1 and Kidney Disease in African Americans.

Authors:  David J Friedman; Martin R Pollak
Journal:  Trends Endocrinol Metab       Date:  2016-03-03       Impact factor: 12.015

10.  ApoL1, a BH3-only lipid-binding protein, induces autophagic cell death.

Authors:  Siqin Zhaorigetu; Guanghua Wan; Ramesh Kaini; Zeyu Jiang; Chien-an A Hu
Journal:  Autophagy       Date:  2008-11-23       Impact factor: 16.016

View more
  10 in total

1.  The key role of NLRP3 and STING in APOL1-associated podocytopathy.

Authors:  Junnan Wu; Archana Raman; Nathan J Coffey; Xin Sheng; Joseph Wahba; Matthew J Seasock; Ziyuan Ma; Pazit Beckerman; Dorottya Laczkó; Matthew B Palmer; Jeffrey B Kopp; Jay J Kuo; Steven S Pullen; Carine M Boustany-Kari; Andreas Linkermann; Katalin Susztak
Journal:  J Clin Invest       Date:  2021-10-15       Impact factor: 14.808

2.  The Relationship between APOL1 Structure and Function: Clinical Implications.

Authors:  Sethu M Madhavan; Matthias Buck
Journal:  Kidney360       Date:  2020-11-04

3.  Kidney Disease-Associated APOL1 Variants Have Dose-Dependent, Dominant Toxic Gain-of-Function.

Authors:  Somenath Datta; Rama Kataria; Jia-Yue Zhang; Savannah Moore; Kaitlyn Petitpas; Adam Mohamed; Nathan Zahler; Martin R Pollak; Opeyemi A Olabisi
Journal:  J Am Soc Nephrol       Date:  2020-07-16       Impact factor: 10.121

4.  Joint Associations of Maternal-Fetal APOL1 Genotypes and Maternal Country of Origin With Preeclampsia Risk.

Authors:  Xiumei Hong; Avi Z Rosenberg; Boyang Zhang; Elizabeth Binns-Roemer; Victor David; Yiming Lv; Rebecca C Hjorten; Kimberly J Reidy; Teresa K Chen; Guoying Wang; Yuelong Ji; Claire L Simpson; Robert L Davis; Jeffrey B Kopp; Xiaobin Wang; Cheryl A Winkler
Journal:  Am J Kidney Dis       Date:  2020-12-22       Impact factor: 11.072

Review 5.  Macrophage polarization in innate immune responses contributing to pathogenesis of chronic kidney disease.

Authors:  Hewang Lee; Michael B Fessler; Peng Qu; Jurgen Heymann; Jeffrey B Kopp
Journal:  BMC Nephrol       Date:  2020-07-13       Impact factor: 2.388

6.  Vascular Inflammation in Lungs of Patients with Fatal Coronavirus Disease 2019 (COVID-19): Possible Role for the NLRP3 Inflammasome.

Authors:  Oindrila Paul; Jian Qin Tao; Eric West; Leslie Litzky; Michael Feldman; Kathleen Montone; Chamith Rajapakse; Christian Bermudez; Shampa Chatterjee
Journal:  Res Sq       Date:  2021-09-01

Review 7.  The evolving story of apolipoprotein L1 nephropathy: the end of the beginning.

Authors:  Parnaz Daneshpajouhnejad; Jeffrey B Kopp; Cheryl A Winkler; Avi Z Rosenberg
Journal:  Nat Rev Nephrol       Date:  2022-02-25       Impact factor: 42.439

8.  Pulmonary vascular inflammation with fatal coronavirus disease 2019 (COVID-19): possible role for the NLRP3 inflammasome.

Authors:  Oindrila Paul; Jian Qin Tao; Eric West; Leslie Litzky; Michael Feldman; Kathleen Montone; Chamith Rajapakse; Christian Bermudez; Shampa Chatterjee
Journal:  Respir Res       Date:  2022-02-10

9.  APOL1 C-Terminal Variants May Trigger Kidney Disease through Interference with APOL3 Control of Actomyosin.

Authors:  Sophie Uzureau; Laurence Lecordier; Pierrick Uzureau; Dorle Hennig; Jonas H Graversen; Fabrice Homblé; Pepe Ekulu Mfutu; Fanny Oliveira Arcolino; Ana Raquel Ramos; Rita M La Rovere; Tomas Luyten; Marjorie Vermeersch; Patricia Tebabi; Marc Dieu; Bart Cuypers; Stijn Deborggraeve; Marion Rabant; Christophe Legendre; Søren K Moestrup; Elena Levtchenko; Geert Bultynck; Christophe Erneux; David Pérez-Morga; Etienne Pays
Journal:  Cell Rep       Date:  2020-03-17       Impact factor: 9.423

10.  Structures of the ApoL1 and ApoL2 N-terminal domains reveal a non-classical four-helix bundle motif.

Authors:  Mark Ultsch; Michael J Holliday; Stefan Gerhardy; Paul Moran; Suzie J Scales; Nidhi Gupta; Francesca Oltrabella; Cecilia Chiu; Wayne Fairbrother; Charles Eigenbrot; Daniel Kirchhofer
Journal:  Commun Biol       Date:  2021-07-27
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.